智飞生物(300122.SZ)：带状疱疹mRNA疫苗临床试验申请获得受理

Core Viewpoint - Zhifei Biological (300122.SZ) has received a clinical trial application acceptance notice from the National Medical Products Administration for its shingles mRNA vaccine developed by its wholly-owned subsidiary, Anhui Zhifei Longkema Biological Pharmaceutical Co., Ltd [1] Group 1 - The clinical trial acceptance number is CXSL2500961 [1] - The company can commence clinical trials within 60 days if no negative or questioning opinions are received from the drug review center [1]